| 000 | 01305 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250516002833.0 | ||
| 264 | 0 | _c20110711 | |
| 008 | 201107s 0 0 eng d | ||
| 022 | _a1096-0295 | ||
| 024 | 7 |
_a10.1016/j.yrtph.2010.09.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTeschke, Rolf | |
| 245 | 0 | 0 |
_aRegulatory causality evaluation methods applied in kava hepatotoxicity: are they appropriate? _h[electronic resource] |
| 260 |
_bRegulatory toxicology and pharmacology : RTP _cFeb 2011 |
||
| 300 |
_a1-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdverse Drug Reaction Reporting Systems _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aAnti-Anxiety Agents _xadverse effects |
| 650 | 0 | 4 | _aCausality |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xetiology |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKava |
| 650 | 0 | 4 |
_aPlant Extracts _xadverse effects |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aWorld Health Organization |
| 700 | 1 | _aWolff, Albrecht | |
| 773 | 0 |
_tRegulatory toxicology and pharmacology : RTP _gvol. 59 _gno. 1 _gp. 1-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yrtph.2010.09.006 _zAvailable from publisher's website |
| 999 |
_c20185068 _d20185068 |
||